Correlation between fractional flow reserve and myocardial viability as assessed by cardiac magnetic resonance imaging in late-presenting asymptomatic STEMI patients

RCT0 sites70 target enrollmentMarch 6, 2019

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: late-presenting asymptomatic STEMI patients who present after 48 hours of symptom
Sponsor: RCT
Enrollment: 70
Status: Terminated
Last Updated: last year

No summary available.

Registry

who.int

Start Date

March 6, 2019

End Date

August 19, 2019

Last Updated

last year

Study Type

Observational

Sex

All

Sponsor

•1\.Age \>18 years
•2\.All patients between 18\-80 years presenting with STEMI who
•\-were not treated within 48 hours after the onset of symptom to 14 days and did not have post MI angina with stable clinical more than 4 days
•\-Failed thrombolytic therapy and did not undergo pharmacoinvasive in 24 hours with stable clinical more than 4 days
•3\.Angiographic inclusion criteria
•\-At least 50% to 90% diameter stenosis in an IRA on visual estimation of baseline angiography and judged feasible for treatment with PCI by the operator.
•4\.Willing to participate and able to understand, read and sign the informed consent document before the planned procedure

•1\.Total occlusion of IRA
•2\.Pregnancy or planning to become pregnant any time after enrolment into this study.
•3\.Left main stem disease (stenosis \> 50%)
•4\.Known severe cardiac valve dysfunction that will require surgery in the follow\-up period.
•5\.TIMI flow less than 2 of IRA artery.
•6\.Killip class III or IV at presentation
•7\.Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow\-up period.
•8\.Life expectancy of less than one year
•9\. Inability to tolerate Adenosine
•10\. Heavily calcified or tortuous vessel where inability to cross the lesion with a pressure wire is expected.